168 related articles for article (PubMed ID: 25721275)
1. Clinical features of gingival lesions in patients with dystrophic epidermolysis bullosa: a cross-sectional study.
Fortuna G; Aria M; Cepeda-Valdes R; Pollio A; Moreno-Trevino MG; Salas-Alanís JC
Aust Dent J; 2015 Mar; 60(1):18-23. PubMed ID: 25721275
[TBL] [Abstract][Full Text] [Related]
2. Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology.
Fortuna G; Lozada-Nur F; Pollio A; Aria M; Cepeda-Valdes R; Marinkovich MP; Bruckner AL; Salas-Alanís JC
J Oral Pathol Med; 2013 Nov; 42(10):733-40. PubMed ID: 23772832
[TBL] [Abstract][Full Text] [Related]
3. The clinical spectrum of dystrophic epidermolysis bullosa.
Horn HM; Tidman MJ
Br J Dermatol; 2002 Feb; 146(2):267-74. PubMed ID: 11903238
[TBL] [Abstract][Full Text] [Related]
4. Restrictions in oral functions caused by oral manifestations of epidermolysis bullosa.
Stellingsma C; Dijkstra PU; Dijkstra J; Duipmans JC; Jonkman MF; Dekker R
Eur J Dermatol; 2011; 21(3):405-9. PubMed ID: 21609900
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
6. Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment.
Fortuna G; Chainani-Wu N; Lozada-Nur F; Aria M; Cepeda-Valdes R; Pollio A; Marinkovich MP; Martinez-Salazar AE; Mignogna MD; Bruckner AL; Salas-Alanís JC
J Am Acad Dermatol; 2013 Jan; 68(1):83-92. PubMed ID: 22575158
[TBL] [Abstract][Full Text] [Related]
7. Clinical criteria for differentiating between recessive and dominant forms of dystrophic epidermolysis bullosa, elaborated from an analysis of 119 cases.
Nomura K; Imaizumi T; Sato T; Hashimoto I
J Dermatol; 1993 May; 20(5):269-75. PubMed ID: 8340530
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa.
Feinstein JA; Bruckner AL; Chastek B; Anderson A; Roman J
Orphanet J Rare Dis; 2022 Sep; 17(1):367. PubMed ID: 36175960
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa.
Dănescu S; Has C; Senila S; Ungureanu L; Cosgarea R
J Eur Acad Dermatol Venereol; 2015 May; 29(5):899-903. PubMed ID: 25201089
[TBL] [Abstract][Full Text] [Related]
10. Genotype-oropharyngeal phenotype correlation in Mexican patients with dystrophic epidermolysis bullosa.
Fortuna G; Pollio A; Aria M; Moreno-Trevino MG; Marasca F; Salas-Alanís JC
Int J Oral Maxillofac Surg; 2014 Apr; 43(4):491-7. PubMed ID: 24210835
[TBL] [Abstract][Full Text] [Related]
11. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.
Ouragini H; Cherif F; Kassar S; Floriddia G; Pascucci M; Daoud W; Osman-Dhahri AB; Boubaker S; Castiglia D; Abdelhak S
J Dermatol Sci; 2009 May; 54(2):114-20. PubMed ID: 19261445
[TBL] [Abstract][Full Text] [Related]
13. [Syndromes 13. Epidermolysis bullosa].
Meijndert L; Jonkman MF
Ned Tijdschr Tandheelkd; 1999 Aug; 106(8):302-5. PubMed ID: 11930425
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
Kwon IJ; Kim SE; Kim SC; Lee SE
J Dermatol; 2024 Mar; 51(3):441-447. PubMed ID: 38115742
[TBL] [Abstract][Full Text] [Related]
16. Burden of itch in epidermolysis bullosa.
Snauwaert JJ; Yuen WY; Jonkman MF; Moons P; Naulaers G; Morren MA
Br J Dermatol; 2014 Jul; 171(1):73-8. PubMed ID: 24506095
[TBL] [Abstract][Full Text] [Related]
17. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study.
Chiaverini C; Charlesworth A; Fernandez A; Barbarot S; Bessis D; Bodemer C; Bursztejn AC; Cobo AM; Del Rio M; D'Incan M; Labrèze C; Langlet C; Mazereeuw J; Miquel J; Vabres P; Meneguzzi G; Lacour JP
Br J Dermatol; 2014 Apr; 170(4):901-6. PubMed ID: 24252097
[TBL] [Abstract][Full Text] [Related]
18. Dystrophic epidermolysis bullosa in goats.
Medeiros GX; Riet-Correa F; Barros SS; Soares MP; Dantas AF; Galiza GJ; Simões SV; Borges AS
J Comp Pathol; 2013 May; 148(4):354-60. PubMed ID: 23123123
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the MMP1 gene promoter region polymorphism--1607 2G with recessive dystrophic epidermolysis bullosa disease severity in northeastern Mexican patients.
Garza-Gómez J; Cerda-Flores RM; Gómez-Flores M; Salas-Alanís JC; Ocampo-Candiani J; Martínez-Garza LE; South AP; Gallardo-Blanco HL
Int J Dermatol; 2014 Aug; 53(8):985-90. PubMed ID: 24899116
[TBL] [Abstract][Full Text] [Related]
20. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations.
Schumann H; Has C; Kohlhase J; Bruckner-Tuderman L
Br J Dermatol; 2008 Aug; 159(2):464-9. PubMed ID: 18565177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
